Telcon RF Pharmaceutical

200230 · KOSDAQ · Health Care · SMALL CAP

An acquisition.

Telcon RF Pharmaceutical disclosed an acquisition of KPM Tech, worth US$14.6M.

M&A(Decision to acquire shares/equity in another company)· FILED 2026-07-03· RCEPT 20260703900769

US$14.6MDeal value
14.4%vs. company assets

Converted at 1 USD ≈ ₩1,542.13 (filing-date rate, 2026-07-02 close)

What happened

Telcon RF Pharmaceutical disclosed an acquisition of KPM Tech, worth US$14.6M.

For context, this deal is worth about 14.4% of the company's own total assets.

TargetKPM Tech
Deal valueUS$14.6M
vs. company assets14.4%
Filed2026-07-03, Decision to acquire shares/equity in another company
SourceDART rcept 20260703900769 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.